Opposite Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology


Autoria(s): BHATTACHARYYA, Sagnik; MORRISON, Paul D.; FUSAR-POLI, Paolo; MARTIN-SANTOS, Rocio; BORGWARDT, Stefan; WINTON-BROWN, Toby; NOSARTI, Chiara; O`CARROLL, Colin M.; SEAL, Marc; ALLEN, Paul; MEHTA, Mitul A.; STONE, James M.; TUNSTALL, Nigel; GIAMPIETRO, Vincent; KAPUR, Shitij; MURRAY, Robin M.; ZUARDI, Antonio W.; CRIPPA, Jose A.; ATAKAN, Zerrin; MCGUIRE, Philip K.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Delta-9-tetrahydrocannabinol (Delta-9-THC) and Cannabidiol (CBD), the two main ingredients of the Cannabis sativa plant have distinct symptomatic and behavioral effects. We used functional magnetic resonance imaging (fMRI) in healthy volunteers to examine whether Delta-9-THC and CBD had opposite effects on regional brain function. We then assessed whether pretreatment with CBD can prevent the acute psychotic symptoms induced by Delta-9-THC. Fifteen healthy men with minimal earlier exposure to cannabis were scanned while performing a verbal memory task, a response inhibition task, a sensory processing task, and when viewing fearful faces. Subjects were scanned on three occasions, each preceded by oral administration of Delta-9-THC, CBD, or placebo. BOLD responses were measured using fMRI. In a second experiment, six healthy volunteers were administered Delta-9-THC intravenously on two occasions, after placebo or CBD pretreatment to examine whether CBD could block the psychotic symptoms induced by Delta-9-THC. Delta-9-THC and CBD had opposite effects on activation relative to placebo in the striatum during verbal recall, in the hippocampus during the response inhibition task, in the amygdala when subjects viewed fearful faces, in the superior temporal cortex when subjects listened to speech, and in the occipital cortex during visual processing. In the second experiment, pretreatment with CBD prevented the acute induction of psychotic symptoms by Delta-9-tetrahydrocannabinol. Delta-9-THC and CBD can have opposite effects on regional brain function, which may underlie their different symptomatic and behavioral effects, and CBD`s ability to block the psychotogenic effects of Delta-9-THC. Neuropsychopharmacology (2010) 35, 764-774; doi:10.1038/npp.2009.184; published online 18 November 2009

Psychiatry Research Trust, UK

Medical Research Council, UK

Biomedial Research Centre

Beckley Foundation

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) Productivity fellowship

Identificador

NEUROPSYCHOPHARMACOLOGY, v.35, n.3, p.764-774, 2010

0893-133X

http://producao.usp.br/handle/BDPI/24639

10.1038/npp.2009.184

http://dx.doi.org/10.1038/npp.2009.184

Idioma(s)

eng

Publicador

NATURE PUBLISHING GROUP

Relação

Neuropsychopharmacology

Direitos

restrictedAccess

Copyright NATURE PUBLISHING GROUP

Palavras-Chave #Delta-9-tetrahydrocannabinol #Cannabidiol #psychosis #anxiety #fMRI #HUMAN AMYGDALA #NEURAL-BASIS #CANNABINOIDS #SCHIZOPHRENIA #MEMORY #PSYCHOSIS #MARIJUANA #COGNITION #MOTOR #DELTA(9)-THC #Neurosciences #Pharmacology & Pharmacy #Psychiatry
Tipo

article

original article

publishedVersion